Potent statin beats ezetimibe addition after acute MI

Switching to a high potency statin is associated with better survival after acute MI when compared to adding ezetimibe, a study from Scotland has suggested.

For patients initially prescribed simvastatin monotherapy after an acute MI, a switch to a drug such as atorvastatin or rosuvastatin was associated with a 28% reduction in mortality (Hazard Ratio 0.72) during a mean follow up of 3.2 years, according to a restrospective observational study conducted by researchers from